메뉴 건너뛰기




Volumn 10, Issue 1, 2008, Pages 31-34

Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: An open-label study

(22)  Vossler, David G a,b   Conry, Joan A c   Murphy, Jerome V d   Boustany, Rose Mary e   Legarda, Stella f   Ruggles, Kevin g   Schachter, Steven h   Krishnamurthy, Kaackuzhali h   Sheth, Raj i   Vazquez, Blanca j   Barkley, Greg k   Chugani, Harry l   Duchowny, Michael m   Flamini, Robert n   Sirven, Joseph o   Uthman, Basim p   Wheless, James q   Asconape, Jorge r   Miller, C Steve s   Pellock, John t   more..


Author keywords

Antiepileptic drug; Myoclonic seizures; Progressive myoclonic epilepsy; Zonisamide

Indexed keywords

CLONAZEPAM; DIAZEPAM; LAMOTRIGINE; LORAZEPAM; VALPROIC ACID; ZONISAMIDE;

EID: 41949083860     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: 10.1684/epd.2008.0168     Document Type: Article
Times cited : (38)

References (8)
  • 1
    • 0036233861 scopus 로고    scopus 로고
    • Progressive Myoclonic Epilepsies
    • Conry JA. Progressive Myoclonic Epilepsies. J Child Neurol 2002; 17 (Suppl. 1): S80-S84.
    • (2002) J Child Neurol , vol.17 , Issue.SUPPL. 1
    • Conry, J.A.1
  • 2
    • 41949110727 scopus 로고    scopus 로고
    • Eisai Ltd. Zonegran Summary of Product Characteristics last updated 14 May, available at
    • Eisai Ltd. Zonegran Summary of Product Characteristics (last updated 14 May 2007). Electronic Medicines Compendium (available at http://emc.medicines. org.uk/).
    • (2007)
  • 3
    • 33748676917 scopus 로고    scopus 로고
    • Report of the ILAE classification core group
    • Engel Jr. J. Report of the ILAE classification core group. Epilepsia 2006; 47: 1558-68.
    • (2006) Epilepsia , vol.47 , pp. 1558-1568
    • Engel Jr., J.1
  • 4
    • 0023900138 scopus 로고
    • Progressive myoclonus epilepsy treated with zonisamide
    • Henry TR, Leppik IE, Gumnit RJ, et al. Progressive myoclonus epilepsy treated with zonisamide. Neurology 1988; 38: 928-31.
    • (1988) Neurology , vol.38 , pp. 928-931
    • Henry, T.R.1    Leppik, I.E.2    Gumnit, R.J.3
  • 5
    • 0037461356 scopus 로고    scopus 로고
    • Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy
    • Kinrions P, Ibrahim N, Murphy K, et al. Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy. Neurology 2003; 60: 1394-5.
    • (2003) Neurology , vol.60 , pp. 1394-1395
    • Kinrions, P.1    Ibrahim, N.2    Murphy, K.3
  • 6
    • 0031962476 scopus 로고    scopus 로고
    • Zonisamide for progressive myoclonus epilepsy: Long-term observations in seven patients
    • Kyllerman M, Ben-Menachem E. Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 1998; 29: 109-14.
    • (1998) Epilepsy Res , vol.29 , pp. 109-114
    • Kyllerman, M.1    Ben-Menachem, E.2
  • 7
    • 0242659220 scopus 로고    scopus 로고
    • Classification of the myoclonic epilepsies
    • Leppik IE. Classification of the myoclonic epilepsies. Epilepsia 2003; 44(Suppl. 11): 2-6.
    • (2003) Epilepsia , vol.44 , Issue.SUPPL. 11 , pp. 2-6
    • Leppik, I.E.1
  • 8
    • 33645079375 scopus 로고    scopus 로고
    • Antimyoclonic effect of levetiracetam in MERRF syndrome
    • Mancuso M, Galli R, Pizzanelli C, et al. Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 2006; 243: 97-9.
    • (2006) J Neurol Sci , vol.243 , pp. 97-99
    • Mancuso, M.1    Galli, R.2    Pizzanelli, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.